n-methyladenosine has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dai, Y; Ding, X; Fang, Y; Hu, J; Liang, Y; Liu, H; Lu, Z; Ning, Y; Song, N; Teng, J; Zhu, J; Zou, J | 1 |
| Lan, J; Pan, Q; Shi, X; Tao, Q; Xu, B | 1 |
2 other study(ies) available for n-methyladenosine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
METTL14 aggravates podocyte injury and glomerulopathy progression through N
Topics: Adenosine; Animals; Apoptosis; Autophagy; Cytoprotection; Diabetic Nephropathies; Disease Progression; Down-Regulation; Doxorubicin; Gene Silencing; Glycation End Products, Advanced; Inflammation; Male; Methyltransferases; Mice, Inbred C57BL; Models, Biological; Podocytes; RNA, Messenger; Sirtuin 1; Up-Regulation | 2021 |
WTAP-mediated N
Topics: Adenosine; Animals; Cell Cycle Proteins; Cytokines; Diabetes Mellitus; Diabetic Nephropathies; Histone Acetyltransferases; Humans; Inflammasomes; Inflammation; Kidney; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; RNA Splicing Factors; RNA, Messenger | 2022 |